Skip to main content

Table 1 Patient clinical and histological characteristics

From: Downregulation of EphA5 by promoter methylation in human prostate cancer

 

Prostate cancer (%)

BPH (%)

Case, n

45

39

Age (mean ± SD, years)

69.5 ± 10.3

63.6 ± 9.1

TNM

T1

1 (2.2)

 

T2

12 (26.7)

T3

14 (31.1)

T4

18 (40.0)

Gleason score

6-7

22 (48.9)

 

8-10

23 (51.1)

PSA (ng/ml)

<4.0

2 (4.4)

4 (10.3)

4.0–10.0

7 (15.6)

21 (53.8)

>10.0

36 (80.0)

14 (35.9)

Prostate volume (ml)

<30

14 (31.1)

8 (20.5)

30–50

17 (37.8)

12 (30.8)

>50

14 (31.1)

19 (48.7)